| Dr David P Stanley, MD | |
|
1150 N 18th St Ste 102, Abilene, TX 79601-2948 | |
| (325) 670-6500 | |
| (325) 676-8046 |
| Full Name | Dr David P Stanley |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 36 Years |
| Location | 1150 N 18th St Ste 102, Abilene, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1730215047 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | J3381 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hendrick Medical Center | Abilene, TX | Hospital |
| Rolling Plains Memorial Hospital | Sweetwater, TX | Hospital |
| Texas Health Harris Methodist Hospital Stephenvill | Stephenville, TX | Hospital |
| Brownwood Regional Medical Center | Brownwood, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Williams Trotter And Associates | 7113985466 | 4 |
News Archive
A single overactive enzyme worsens the two core defects of diabetes—impaired insulin sensitivity and overproduction of glucose—suggesting that a drug targeting the enzyme could help correct both at once, according to mouse studies done by researchers at Columbia University Medical Center. The findings were published today in the online edition of Cell Metabolism.
The Food and Drug Administration (FDA) received reports of malignancies in children using tumor necrosis factor (TNF) blockers, raising concerns of an associated risk and prompting an investigation. Researchers from the FDA set out to identify all reports of malignancy in children using infliximab, etanercept, and adalimumab and their report is published in the August issue of Arthritis & Rheumatism, a journal of the American College of Rheumatology.
A visible and growing number of transgender children in North America live in alignment with their gender identity rather than their natal sex, yet scientific research has largely ignored them. No longer, says Nicholas Eaton, PhD, an Assistant Professor of Psychology at Stony Brook University. Dr. Eaton and his colleagues at the TransYouth Project have started the first large-scale, national study of socially-supported transgender kids.
Phil Hagerman, president and CEO of Diplomat Specialty Pharmacy in Flint, has been named Grant Thornton Leader & Innovator of the Year.
A landmark autism study and a dramatic success for gene therapy in reversing inherited blindness, both at The Children's Hospital of Philadelphia, were recognized among the top scientific achievements in 2009, according to three national publications: Time magazine, Discover magazine and the journal Science.
› Verified 4 days ago
| Entity Name | Williams Trotter & Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174659486 PECOS PAC ID: 7113985466 Enrollment ID: O20050103000716 |
News Archive
A single overactive enzyme worsens the two core defects of diabetes—impaired insulin sensitivity and overproduction of glucose—suggesting that a drug targeting the enzyme could help correct both at once, according to mouse studies done by researchers at Columbia University Medical Center. The findings were published today in the online edition of Cell Metabolism.
The Food and Drug Administration (FDA) received reports of malignancies in children using tumor necrosis factor (TNF) blockers, raising concerns of an associated risk and prompting an investigation. Researchers from the FDA set out to identify all reports of malignancy in children using infliximab, etanercept, and adalimumab and their report is published in the August issue of Arthritis & Rheumatism, a journal of the American College of Rheumatology.
A visible and growing number of transgender children in North America live in alignment with their gender identity rather than their natal sex, yet scientific research has largely ignored them. No longer, says Nicholas Eaton, PhD, an Assistant Professor of Psychology at Stony Brook University. Dr. Eaton and his colleagues at the TransYouth Project have started the first large-scale, national study of socially-supported transgender kids.
Phil Hagerman, president and CEO of Diplomat Specialty Pharmacy in Flint, has been named Grant Thornton Leader & Innovator of the Year.
A landmark autism study and a dramatic success for gene therapy in reversing inherited blindness, both at The Children's Hospital of Philadelphia, were recognized among the top scientific achievements in 2009, according to three national publications: Time magazine, Discover magazine and the journal Science.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr David P Stanley, MD Po Box 3138, Abilene, TX 79604-3138 Ph: (325) 670-6500 | Dr David P Stanley, MD 1150 N 18th St Ste 102, Abilene, TX 79601-2948 Ph: (325) 670-6500 |
News Archive
A single overactive enzyme worsens the two core defects of diabetes—impaired insulin sensitivity and overproduction of glucose—suggesting that a drug targeting the enzyme could help correct both at once, according to mouse studies done by researchers at Columbia University Medical Center. The findings were published today in the online edition of Cell Metabolism.
The Food and Drug Administration (FDA) received reports of malignancies in children using tumor necrosis factor (TNF) blockers, raising concerns of an associated risk and prompting an investigation. Researchers from the FDA set out to identify all reports of malignancy in children using infliximab, etanercept, and adalimumab and their report is published in the August issue of Arthritis & Rheumatism, a journal of the American College of Rheumatology.
A visible and growing number of transgender children in North America live in alignment with their gender identity rather than their natal sex, yet scientific research has largely ignored them. No longer, says Nicholas Eaton, PhD, an Assistant Professor of Psychology at Stony Brook University. Dr. Eaton and his colleagues at the TransYouth Project have started the first large-scale, national study of socially-supported transgender kids.
Phil Hagerman, president and CEO of Diplomat Specialty Pharmacy in Flint, has been named Grant Thornton Leader & Innovator of the Year.
A landmark autism study and a dramatic success for gene therapy in reversing inherited blindness, both at The Children's Hospital of Philadelphia, were recognized among the top scientific achievements in 2009, according to three national publications: Time magazine, Discover magazine and the journal Science.
› Verified 4 days ago
Dr. Maureen E Trotter, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 1150 N 18th St Ste 102, Abilene, TX 79601 Phone: 325-670-6500 Fax: 325-676-8046 | |
Dr. Mark A Pollock, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 1150 N 18th St Ste 102, Abilene, TX 79601 Phone: 325-670-6500 Fax: 325-676-8046 | |
Dr. Bertram B Geeslin Jr., MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 1150 N 18th St Ste 102, Abilene, TX 79601 Phone: 325-691-2416 Fax: 325-676-8046 | |
Dr. Othon Almanza, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 1900 Pine St, Abilene, TX 79601 Phone: 325-670-2817 | |
Dr. Jerry C Depriest, MD Pathology Medicare: Medicare Enrolled Practice Location: 1150 N 18th St Ste 102, Abilene, TX 79601 Phone: 325-670-6500 Fax: 325-676-8046 | |
Dr. James I Duff, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 1150 N 18th St Ste 102, Abilene, TX 79601 Phone: 325-670-6500 Fax: 325-676-8046 |